Ramtin Agah - 25 Aug 2021 Form 3/A - Amendment Insider Report for RenovoRx, Inc. (RNXT)

Role: Chief Medical Officer, Director, 10%+ Owner
Signature: /s/ Ramtin Agah, MD
Issuer symbol: RNXT
Transactions as of: 25 Aug 2021
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 17 Jun 2022, 16:05:49 UTC
Date Of Original Report: 25 Aug 2021
Next filing: 17 Jun 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	RNXT	Convertible Notes							25 Aug 2021	Common Stock	1,295		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Upon the closing of the Issuer's initial public offering, each Convertible Note, plus accrued interest, will automatically convert into (i) one share of common stock and (ii) one five-year warrant to purchase one share of common stock at an exercise price equal to $10.80 per share.

Remarks:

This report on Form 3/A is filed to include the reported convertible notes in Table 2. Due to an administrative error, the notes were omitted from the Form 3 filed with the SEC on August 25, 2021.